Back to search
Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous AOC 1020 for the Treatment of Facioscapulohumer…
The data to be collected is intended to help healthcare providers make important medical and financial decisions concerning FSHD1, through an enhanced understan…
A Phase 2 Open-label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of AOC 1020 Administered Intravenously to Participants with Fa…
A Randomized, Double-blind, Placebo-controlled, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory Effica…